Retia Medical, LLC, is a digital health company that aims to improve guided care of critically ill patients in operating rooms and intensive care units.
The Argos® Hemodynamic Monitor, developed by industry-leading experts in physiology, signal processing and algorithm development is backed by over 15 years of research. The Argos® is more consistently accurate, easier-to-use and more affordable than competing options, enabling critical care teams to make confident, data-driven decisions to enhance the guided care of their highest risk patients.
The Argos Monitor has both FDA 510(k) and the CE Mark.
The top 5 hospitals in the US and several other leading academic medical centers use the Argos to guide care for thousands of patients worldwide.